Nasdaq
ZBIO
Zenas BioPharma, Inc.
- Health Care
- Listed 2024
- 1 day
- +1.0%
- 1 month
- +16.2%
- 1 year
- +105%
$32.17 · Mkt cap $2.03B
At the 6 Aug 2026 close
Nasdaq
Zenas BioPharma, Inc.
$32.17 · Mkt cap $2.03B
At the 6 Aug 2026 close
Zenas BioPharma, Inc. trades under the ticker ZBIO on Nasdaq, in the Health Care sector (Biotechnology: Pharmaceutical Preparations). It has been listed since 2024. Its market capitalisation is $2.03B. The last closing price was $32.17, on 6 Aug 2026. No price-to-earnings ratio is shown, because it did not report positive earnings in its last annual filing. Over the past year the share price is +105%, and +16.2% over the past month. Returns are price returns and exclude dividends.
This page exists because ZBIO is one of the shares What A Share can show you. It is not a recommendation, and its appearance here says nothing about whether the company is worth owning.